DOXIL (doxorubicin HCl liposome injection)
Print Back
 
Site Map

DOXIL Home Page

For Patients

Understand Your Options
About Ovarian Cancer
Choosing a Treatment Option
Evaluating CA-125 Levels

Learn the Facts About DOXIL
About DOXIL
Efficacy
Safety Information
Common Side Effects

Optimize Your DOXIL Treatment
What to Expect
Managing Side Effects
Staying On Course
Working Together

Find the Support You Need
Community Connection
Resource Library

    Cancer and Intimacy (PDF)
    Meet the Challenge: What to Expect from DOXIL (Video)
    Nutrition Knowledge is Power (PDF)
    Questions & Answers About DOXIL (PDF)
    Questions or Topics to Discuss with Your Doctor (PDF)
    Tips and Suggestions for Patients Receiving Treatment (PDF)
Request More Information

For Caregivers

For Healthcare Professionals

Glossary
Frequently Asked Questions
Full Prescribing Information (PDF)
Legal Notice
Privacy Policy

 

 


 

Doxil (doxorubicin HCl), is a prescription medicine that is administered intravenously by your healthcare professional. DOXIL is used to treat patients with ovarian cancer that has progressed or recurred after platinum-based chemotherapy.

Please read Important Safety Information below, and talk to your healthcare professional to learn more about DOXIL.


Important Safety Information

Serious and possibly permanent heart-related side effects that may lead to congestive heart failure can occur in patients treated with DOXIL. Inform your doctor of any history of heart disease, radiation to your chest, or prior chemotherapy. Your doctor may monitor your heart function.

Infusion reactions may occur during administration. Be sure to tell your doctor if you have any symptoms during infusion, including: flushing, shortness of breath, facial swelling, headaches, chills, back pain, tightness in your chest or throat, dizziness, or lightheadedness. For most patients, these reactions have resolved within several hours to a day once the infusion is stopped, or for some patients with slowing of the infusion rate. However, in some cases, these reactions may be serious and sometimes life threatening, though they are rarely fatal.

DOXIL may severely reduce the number of blood cells (red blood cells, white blood cells, and platelets) in your body. Your doctor may adjust or delay your dose of DOXIL if this occurs.

Your doctor may adjust your dose of DOXIL if you have liver problems.

You should not take DOXIL if you are nursing. If you are pregnant or are planning to become pregnant, inform your doctor.

You should not take DOXIL if you are allergic to doxorubicin HCI or the components of DOXIL.

The most common side effects of DOXIL are:

  • Hand-Foot Syndome (HFS): Tingling or burning, redness, flaking, bothersome swelling, small blisters, or small sores on palms of hands or soles of feet
  • Stomatitis: Painful redness, swelling, or sores in the mouth
  • Fever: A fever of 100.5oF or higher
  • Neutropenia: Low white blood cell count
  • Nausea, vomiting, tiredness, weakness, rash, shortness of breath, or mild hair loss
  • Loss of appetite
  • Diarrhea

Be sure to tell your doctor immediately if you experience any of these or other symptoms.

DOXIL may make the side effects of other anticancer therapies worse when used in combination.

Following administration, DOXIL may turn urine and other bodily fluids a reddish-orange color. This is due to the color of DOXIL and will go away as the drug leaves the body.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088 (1-800-332-1088).

Please click here for full Product Information in PDF format,for more details.

 

This site is published by Centocor Ortho Biotech Products L.P., which is solely responsible for its contents. It is intended for visitors from the United States.

© Centocor Ortho Biotech Products L.P., 2003-2010.